Haemonetics to draw on revolver for Advanced Cooling acquisition

By Mary-Katherine Stinson

Lexington, Ky., March 5 – Haemonetics Corp. will finance its acquisition of Advanced Cooling Therapy, Inc., d/b/a Attune Medical, through a combination of cash on hand and a draw under its revolving credit facility, according to an 8-K filing with the Securities and Exchange Commission.

Under the terms of the agreement, Haemonetics will acquire Attune Medical for an upfront cash payment of $160 million at closing plus additional contingent consideration based on sales growth in the three years following closing and the achievement of certain other milestones.

The transaction is expected to close in the first quarter of the fiscal 2025 year.

Haemonetics is a Boston-based health care company that provides blood management services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.